BRIJ Medical

Executive Summary

BRIJ Medical is a San Francisco-based private medical device company specializing in surgical closure and wound healing. Founded in 2018, the company has developed the Brijjit Force Modulating Tissue Bridge, a non-invasive, biocompatible device that actively offloads tension around incisions. The product is intended for use as a final skin closure device across plastic, orthopedic, and urgent care surgeries, aiming to reduce wound complications and scarring. By addressing mechanical forces that compromise healing, BRIJ Medical's technology has the potential to improve patient outcomes and reduce healthcare costs associated with wound dehiscence and hypertrophic scars. The company is still in early stages, with no publicly disclosed funding rounds, FDA approvals, or revenue, but its innovative approach places it in a growing market for advanced wound closure solutions.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) submission or clearance for Brijjit device70% success
• Q4 2026Publication of clinical study data on wound complication reduction60% success
• Q1 2027Strategic partnership or distribution agreement with a major surgical supply company50% success